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Abstract: Bean golden mosaic is the most important viral disease affecting 
common beans (Phaseolus vulgaris) in Brazil. It is caused by Bean golden mosaic 
virus (BGMV) and is prevalent in all bean producing areas. Aiming to control the 
disease, a transgenic bean elite line was developed with an intron-hairpin 
construction to silence the AC1 viral gene. This line shows high resistance to 
BGMV with the capacity to contain the replication of the virus both in the green 
house and in the field. The silencing through small interfering RNAs (siRNA) is 
sequence specific and a high identity to the transgene is required to assure 
resistance since gene silencing can be inefficient when the identity is lower than 
90%. To guarantee the broad use of transgenic cultivars in the different regions of 
the country, we have analyzed the sequence of begomoviruses isolated from bean 
samples from several states. A total of 85 bean samples were collected. Total DNA 
from dried leaves was extracted with Extract-N-Amp™ Plant PCR Kit followed by 
RCA reaction using Phi-29 polymerase. PCR reaction with primers BGMV-HPXHO 
and PAR1c484 amplified a ~1.3Kb fragment encompassing part o AC1 gene, the 
entire common region and part of the coat protein gene. Sequences obtained from 
25 isolates were analyzed and compared with corresponding sequences from 
BGMV-[BR:GO 87-1] (M88686). The identity was between 85,2% and 97,4% 
indicating that most likely only BGMV is infecting common beans in the field. 
Although some isolates have sequence identities lower than 90% over the entire 
PCR fragment, the portion corresponding to that used in the RNAi construction is 
highly identical (between 90,5 and 98,8%). These results will warrant the large 
scale use of transgenic cultivars resistant to BGMV based on RNAi over the 
Brazilian territory. 
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